Search
News
AMC Stock Jumps 6% After Attack on "Inexcusable" and "Vile" Robinhood Practices
Key PointsAMC CEO Adam Aron criticized Robinhood for its tokenized stocks and demanded that the company stop the trading of AMC stock tokens.Robinhood CEO Vlad Tenev responded to Aron on X by asking what the concern was.Aron said marketing a security posing as AMC that does not comply with U.S. secu...Tiger News
Fri, Sep 4
Dare to go further: Baseus Brings New Charging, Audio and Security Innovations to IFA 2026
BERLIN, Sept. 4, 2026 /PRNewswire/ -- Baseus, a user-centric consumer technology brand, showcased a new lineup of charging, audio, and smart-security innovations at IFA 2026. Headlining the showcase are the Dark Cherry Collection, the Baseus MC2 NC open-ear clip-on earbuds, and the PrimeSentinel U2 ...PR Newswire
Fri, Sep 4
DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES
Dimerix successfully enters into non-dilutive facility agreements to access A$34 million[1] with a syndicate of Australian and U.S. independent lenders, including the previously announced initial facility of A$10 million[2] Facility terms for all Lenders substantially consistent with the previousl...PR Newswire
Fri, Sep 4
Sharon AI Selects Rafay Systems to Support AI Infrastructure Orchestration Platform at Scale
Five-year strategic agreement establishes a standardized orchestration and operations platform across Sharon AI's expanding AI Factory environments NEW YORK, Sept. 4, 2026 /PRNewswire/ -- SharonAI Holdings Inc. (NASDAQ: SHAZ) ("Sharon AI" or the "Company"), a leading Australian ...PR Newswire
Fri, Sep 4
HoneyNaps Develops Next-Generation Wireless PSG system Using Four Skin Patches
Patch-based wireless sensors and AI-powered analysis combine to improve patient comfort and clinical efficiency in polysomnography New platform reduces more than 24 wired sensors to four compact patches, with potential applications in hospitals, home sleep testing and remote monitoring BOSTON,...PR Newswire
Fri, Sep 4
ECOVACS Launches WINBOT W2S PRO OMNI, the Latest Addition to the World's #1 Robotic Window Cleaner Line
The latest WINBOT combines upgraded edge-to-edge scrubbing, cordless cleaning, intelligent navigation and comprehensive safety for a more effortless way to keep windows clean SAN FRANCISCO, Sept. 4, 2026 /PRNewswire/ -- ECOVACS Robotics today launched theWINBOT W2S PRO OMNI robotic window cleaner a...PR Newswire
Fri, Sep 4
Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate
FDA clearance enables initiation of a Phase 1 clinical trial and advances the first AD2C-generated candidate into clinical development ALAMEDA, Calif. and TAIPEI, Sept. 4, 2026 /PRNewswire/ -- Acepodia (6976: TT), a clinical-stage biotechnology company developing next-generation cell therapies and ...PR Newswire
Fri, Sep 4
JA Takes Integrated Solar-Plus-Storage Solutions on the Road Across Europe
PABIANICE, Poland, Sept. 4, 2026 /PRNewswire/ -- JA has officially launched its first European roadshow, Journey Ahead: JA Roadshow 2026, with the inaugural stop in Poland. The mobile showcase will travel across the continent over the next eight weeks, bringing JA's latest PV and energy storage ...PR Newswire
Fri, Sep 4
From China’s Clinical Settings to a Global AI4S Foundation: How Diagens-B (02526.HK) Builds a Medical Imaging Model Factory
AI for Science (AI4S) is reshaping the paradigm of life science exploration. Spanning drug discovery, genetic analysis and clinical diagnosis and treatment, AI has emerged as a core engine driving breakthroughs in biological research. In medical imaging, a pivotal track for healthcare AI innovation, AI4S has evolved beyond image reading assistance to build generalized underlying intelligence infrastructure for clinical and scientific research.As a distinctive practitioner in this global trend, Diagens Technology Co., Ltd. (02526.HK, “Diagens Tech”) does not engage in pharmaceutical R&D, but builds fundamental AI research infrastructure to empower life science imaging analysis. The launch of the world’s first foundational medical imaging model iMedImage® and the end-to-end platform iMedLoop™ enables hospitals and research institutions to share AI production capabilities through projects and co-development.Most importantly, Diagens Tech has established a commercial closed-loop featuring “data – model development – product – clinical practice – data”, which underpins Diagens Tech’s one-of-a-kind medical imaging AI Model Factory, enabling in-depth scientific research and sustainable commercial resilience.Data Standardization: Building a Data‑Governance System amid Complex Clinical ConditionsMedical imaging data is inherently heterogeneous, a challenge further amplified by China’s diversified clinical settings. Different levels of healthcare facilities nationwide deploy equipment from diverse domestic and international brands and models. Coupled with China’s vast territory and large population, the country has cultivated unique patient cohorts and disease spectrums that are hard to be replicated elsewhere. Direct model training on unprocessed raw data would substantially amplify noise and disruption.Standardization serves as the very first step to convert raw imaging data into high-quality data assets. Powered by intelligent annotation and expert quality control mechanisms, Diagens Tech’s iMedStudio™ delivers multi-layered data refinement through AI precise segmentation, intelligent arbitration and manual expert review, converting raw medical images into standardized training samples. As of end-June 2026, this high-precision data processing pipeline has accumulated approximately 28.95 million annotated samples, supported by a professional team of over 3,000 specialized annotators.Constrained by clinical data security protocols and on-site data collection requirements, standardized medical imaging infrastructure cannot be established overnight. Through nearly a decade of in-depth hospital collaboration, Diagens Tech has fully operationalized its optimized end-to-end data governance pipeline. Its standardized framework eliminates format and annotation inconsistencies while preserving cohort and device diversities. Such heterogeneous data features were deemed constraints in the traditional “one model per disease” approach, yet constitute core advantages for foundational large models. The high-diversity data assets refined from complex real-world clinical scenarios form the cornerstone of robust cross-scenario generalization capabilities.Model Scaling: Transforming Model‑Building from Craftsmanship to Industrialized ProductionThis revolutionary shift in production methodology originated from Diagens Tech’s forward-looking strategic decision in 2017. While industry peers prioritized rapid iteration of disease-specific models, Diagens Tech embarked on a long-term, high-barrier path of independent R&D for medical imaging foundational large models. Built on self-accumulated clinical data assets, this proprietary foundational infrastructure cannot be purchased or rapidly replicated, granting Diagens Tech a multi-year technological lead in foundational model development.Today, the flagship iMedImage® foundational medical imaging model features 104 billion parameters, trained on over 80 million medical images covering 19 mainstream imaging modalities. With this mature foundation in place, new specialty-specific models no longer require full-cycle training from scratch, and can be rapidly deployed via targeted fine-tuning with specialty-specific data. Previously requiring years of data accumulation and iteration, the deployment of specialty-specific models is now compressed to two to three months. As of end-June 2026, Diagens Tech has delivered 158 specialty-specific model projects through cooperation with nearly 100 hospitals nationwide.The interim‑period results deliver quantifiable proof of operational returns. In the first half of 2026, Diagens Tech’s model service revenue reached RMB 94.541 million, representing a year-on-year increase of 101.1% and accounting for 86.9% of total revenue. R&D expenditure stood at approximately RMB 64.12 million, up 67.4% year-on-year. The substantial outperformance of revenue growth over R&D investment growth validates accelerating platform-based economies of scale. Sustained R&D investment underscores ongoing expansion, with industrialized productivity yet to reach full potential.The essence of scaling lies in optimized cost structures. The foundation requires only one-time massive investment, supporting iterative development of unlimited specialty-specific models without repeated high-cost input. Multi-project deployment in parallel enables all online models to benefit synchronously from each foundational model iteration. Rather than relying on individual models, value is accumulated across the entire pipeline, fundamentally transforming medical AI model development from craftsmanship to industrial manufacturing.Replicable Capabilities: Turning Model‑Building into a Reusable On‑Demand ServiceBeyond internal production capabilities, Diagens Tech’s Model Factory is evolving toward service-oriented openness, productizing its mature “foundational pre-training + specialty-specific fine-tuning” paradigm as replicable, accessible services for hospitals and academic research institutions worldwide.This system is underpinned by three core strengths. First, full-process productization. Launched in July 2026, the iMedLoop™ platform solidifies the entire industrial workflow covering data governance, model training, performance evaluation, commercial deployment and clinical feedback iteration. Partner institutions can access complete industrial AI production capabilities via project cooperation and co-development, eliminating the need for in-house pipeline development. Second, cross-modal replicability. Originating from chromosome karyotype analysis scenarios, Diagens Tech’s methodologies have been successfully replicated across 19 imaging modalities, unbound by any specific disease indication. Third, global market accessibility. The full product portfolio complies with NMPA, FDA and CE requirements, with sales networks covering more than 70 countries and regions across six continents.Over the past decade, Diagens Tech has accomplished a groundbreaking transformation rooted in China’s complex real-world clinical ecosystem: upgrading medical imaging AI development from fragmented craftsmanship to a standardized, scalable and exportable Model Factory. With the September Stock‑Connect eligibility window drawing near, this platform‑driven model factory will come onto the radar of mainstream mainland institutional investors for portfolio allocation. As a global industrial‑grade platform for medical‑imaging AI, Diagens Tech will see its scarce market positioning continuously re‑evaluated by southbound capital once it gains Stock‑Connect eligibility.04/09/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.comEQS
Fri, Sep 4
Beko lets the numbers tell the story of easier everyday living
From 40-minute full-load washing and 59-minute oven cleaning to 30% longer freshness, Beko's global brand portfolio turns innovation into measurable benefits for everyday life. ISTANBUL, Sept. 4, 2026 /PRNewswire/ -- Beko, a global leader in home appliances, showcases innovations from across it...PR Newswire
Fri, Sep 4
Cheetah Mobile To Report Second Quarter 2026 Financial Results on September 11, 2026
BEIJING, Sept. 4, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company with a commitment to AI innovation, today announced that it will report its financial results for the second quarter 2026 before the U.S. market opens...PR Newswire
Fri, Sep 4
AI Leads, Future Succeeds: 2026 China International Consumer Electronics Exposition Kicks Off
QINGDAO, China, Sept. 4, 2026 /PRNewswire/ -- On September 4, the 2026 China International Consumer Electronics Exposition (hereinafter referred to as the "CICE") officially opened at the Qingdao International Convention Center (Hongdao Hall). This year's Expo brings together over 300 do...PR Newswire
Fri, Sep 4
Wonderful Raises $550 Million Series C to Scale the AI Operating System for the Enterprise
Funding will accelerate product development and global deployment of the Wonderful AI OS, as enterprises move from isolated AI use cases to organization-wide transformation. AMSTERDAM, Sept. 4, 2026 /PRNewswire/ -- Wonderful, the AI OS for the enterprise, announced the closing of a $550 million Ser...PR Newswire
Fri, Sep 4
Top 5 HK Stock Gainers/Losers (>100B) (9.4)
Hang Seng Index has rose 1.74%, with a year-to-date rose 0.1%; Hang Seng TECH Index has rose 2.27%, with a year-to-date fell 17.2%.MUYUAN(02714) rose 9.21%, with a trading turnover 295.5 Million HKD, and a year-to-date rose 1.6%.LENOVO GROUP(00992) rose 6.09%, with a trading turnover 5.0 Billion HKD...Longport
Fri, Sep 4
Top 10 HK Stock Losers (9.4)
Hang Seng Index has rose 1.74%, with a year-to-date rose 0.1%; Hang Seng TECH Index has rose 2.27%, with a year-to-date fell 17.2%.TRIGIANT(01300) fell 25.88%, with a trading turnover 63.2 Million HKD, and a year-to-date rose 397.5%.FAMEGLOW(03774) fell 16.31%, with a trading turnover 27.9 Million H...Longport
Fri, Sep 4
Top 10 HK Stock Gainers (9.4)
Hang Seng Index has rose 1.74%, with a year-to-date rose 0.1%; Hang Seng TECH Index has rose 2.27%, with a year-to-date fell 17.2%.TOPNC(07688) rose 15.85%, with a trading turnover 84.3 Million HKD, and a year-to-date fell 26.6%.PHANCY(06682) rose 14.66%, with a trading turnover 619.4 Million HKD, a...Longport
Fri, Sep 4
Premarket Movers | Lululemon Plunges 18% on Outlook Cut; Planet Labs Jumps 9%; Zscaler Drops over 3%; ChargePoint Jumps over 2%
Lululemon Athletica fell nearly 18% in premarket trading. The retailer slashed full-year revenue guidance to $10.35B–$10.50B and flagged softness in core leggings, with Q2 leggings sales down about 20%, and said it will step up marketing and seasonal clearance.Planet Labs Pbc rose 9.2%. The satellit...Tiger News
Fri, Sep 4
Chip, Storage Shares Rebound. SOXL up over 5%; Lam Research, SanDisk, Astera Labs, Marvell, ARM, Applied Materials, ASML, Micron up over 2%
Chip, storage shares rebounded in premarket trading. SOXL up over 5%; Lam Research, SanDisk, Astera Labs, Marvell, ARM, Applied Materials, ASML, Micron up over 2%.Tiger News
Fri, Sep 4
DAHON TECH Announces 2026 Interim Results; Revenue and Profit Record Strong Growth
HONG KONG and SHENZHEN, China, Sept. 4, 2026 /PRNewswire/ -- DAHON TECH (HKEX: 2543), a leading global folding bicycle company, announced its interim results for the six months ended June 30, 2026. For the first half of 2026, the Company recorded revenue of approximately US$73 million, representing...PR Newswire
Fri, Sep 4
Diving deeper into real-life home demands, EZVIZ brings next-generation home innovations and products to IFA with expanded application scenarios
HOOFDDORP, Netherlands, Sept. 4, 2026 /PRNewswire/ -- This IFA, EZVIZ explores new frontiers with its full-range products in the smart home hall 1.2. Under the theme "Accelerating Innovation", the company creates an immersive experience at booth 175, featuring anticipated debuts that highlig...PR Newswire
Fri, Sep 4
Featured Tools
Top News
Meta Connect 2026 New Product Roundup: Muse Integrated Into AI Glasses, Can It Drive Meta Revenue Growth?
Qualcomm Extends Long-Term Patent Agreement With Apple, Securing QTL Revenue in Era of In-House iPhone Modems
Today’s Market Recap: 10-Year Treasury Yield Hits Highest Level Since 2007, Major U.S. Indexes Fall, SpaceX Drops Over 4%
Oracle Tumbles 7% as Project Jupiter Data Center Force Majeure Notice Sparks Delay Concerns
Meta Stock Forecast: Muse Monetization Path Is Key as JPMorgan Raises Price Target to $920; Can Stock Hit Record High?
